BillionToOne is trading 10.23% up now at $114.49, supported by broader biotech-sector strength, while no clear company-specific announcement has been identified as the direct catalyst.
- XBI is up 2.07% during regular trading amid optimism around AI-related drug-discovery collaborations and positive clinical news.
- Recent insider selling, including General Counsel Thomas P. Lynch’s approximately $3.87 million planned sale, has not clearly explained the September 22 advance.